By
AmyT on
November 11, 2010
Many of us patient advocates who make the rounds at e-patient and health 2.0 conferences hear an awful lot of talk about “what the patient wants” and how Pharma and device companies should reach out to our communities online. Meanwhile, they’ve been slow to embrace Social Media, and given the controversy over FDA regulations for this, who knows what’s happening internally at these companies as they struggle to form a viable strategy for getting involved?…
Read more »
By
AmyT on
December 10, 2009
Many of you know that the FDA held public hearings on the pharma industry’s use of Social Media mid-last-month. There was much excitement going into this because to date, the FDA has pretty much dodged the subject, and left drugmakers in fear of retribution (see BusinessWeek‘s summary here).
Essentially, since there are no clear rules laid out for how pharma can and can’t advertise their wares online, and talk about them on blogs, social networks,…
Read more »
As you may have noticed, I’m fascinated with where new Web-enabled communication tools are taking us in the world of medicine in healthcare. I’m also a huge admirer of the work of the outspoken and sage John Mack, publisher of Pharma Marketing News and author of the Pharma Marketing Blog. I was therefore delighted when John agreed to make a guest appearance here.
{Note: I referenced John extensively in my own recent post on Pharma…
Read more »
As the Diabetes Social Media Summit hosted by Roche approaches, I’ve been thinking and reading a lot about the question of Pharma engagement here. Is Social Media destined to be just another forum for them to push marketing mantras and build brands? Or can there really be valuable two-way interaction between the chronically drug-dependent (us PWDs, for example) and the industry that sells us our meds?
A whole lot of blogosphere debate is going on,…
Read more »
Today kicks off the American Diabetes Association’s 2009 annual conference, this year in balmy New Orleans. I won’t be responding to emails today, because I’m underway!
It’s actually a nostalgic day for me, because my decision to attend the ADA conference taking place in San Diego four years ago was a milestone — being there amongst the diabetes A-list and seeing all the reams of information, excitement and fanfare around new treatments and products changed my…
Read more »